POTENZA, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 25.826
AS - Asia 11.216
EU - Europa 10.428
SA - Sud America 1.557
AF - Africa 274
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 27
Totale 49.358
Nazione #
US - Stati Uniti d'America 25.419
SG - Singapore 3.372
GB - Regno Unito 2.914
CN - Cina 2.795
IT - Italia 2.240
HK - Hong Kong 1.817
VN - Vietnam 1.295
BR - Brasile 1.168
SE - Svezia 1.168
DE - Germania 940
FI - Finlandia 798
RU - Federazione Russa 566
FR - Francia 459
UA - Ucraina 392
KR - Corea 301
TR - Turchia 289
IN - India 272
ID - Indonesia 227
CA - Canada 205
BD - Bangladesh 168
BG - Bulgaria 168
NL - Olanda 131
AR - Argentina 112
MX - Messico 105
IQ - Iraq 96
JP - Giappone 88
ES - Italia 78
BE - Belgio 71
PL - Polonia 71
ZA - Sudafrica 71
IE - Irlanda 68
CZ - Repubblica Ceca 67
EC - Ecuador 66
PK - Pakistan 63
AT - Austria 61
AE - Emirati Arabi Uniti 59
CO - Colombia 56
PH - Filippine 45
LT - Lituania 44
CL - Cile 43
MA - Marocco 43
KE - Kenya 40
VE - Venezuela 39
MY - Malesia 34
UZ - Uzbekistan 34
SA - Arabia Saudita 29
JO - Giordania 28
AU - Australia 27
IR - Iran 27
PY - Paraguay 27
DZ - Algeria 26
AZ - Azerbaigian 23
BZ - Belize 22
EG - Egitto 22
RO - Romania 22
CH - Svizzera 20
EU - Europa 18
CR - Costa Rica 17
TN - Tunisia 17
UY - Uruguay 17
AL - Albania 16
DK - Danimarca 16
PT - Portogallo 16
SK - Slovacchia (Repubblica Slovacca) 16
IL - Israele 15
JM - Giamaica 15
TW - Taiwan 15
BO - Bolivia 14
NP - Nepal 14
PE - Perù 13
SI - Slovenia 13
OM - Oman 12
RS - Serbia 12
TH - Thailandia 11
GR - Grecia 10
PS - Palestinian Territory 10
BH - Bahrain 9
DO - Repubblica Dominicana 9
KG - Kirghizistan 8
KZ - Kazakistan 8
MK - Macedonia 8
NG - Nigeria 8
BN - Brunei Darussalam 7
BY - Bielorussia 7
CY - Cipro 7
LB - Libano 7
NO - Norvegia 7
QA - Qatar 7
EE - Estonia 6
ET - Etiopia 6
MD - Moldavia 6
NI - Nicaragua 6
PA - Panama 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
AO - Angola 5
GT - Guatemala 5
LU - Lussemburgo 5
PR - Porto Rico 5
Totale 49.277
Città #
Ashburn 2.756
Fairfield 2.630
Santa Clara 2.220
Singapore 2.080
Southend 1.888
Hong Kong 1.800
Woodbridge 1.515
Chandler 1.328
Houston 1.274
Seattle 1.033
San Jose 958
Ann Arbor 891
Wilmington 856
Cambridge 833
Hefei 791
Nyköping 664
Jacksonville 660
Helsinki 606
Dearborn 591
London 530
Beijing 527
Chicago 461
Los Angeles 434
New York 434
Modena 430
Ho Chi Minh City 416
Council Bluffs 296
Hanoi 296
Seoul 276
The Dalles 264
San Diego 248
Milan 225
Munich 196
Salt Lake City 179
Princeton 177
Jakarta 174
Bologna 167
Lauterbourg 164
Sofia 164
Buffalo 159
Eugene 135
Izmir 135
Moscow 135
Fremont 124
Shanghai 121
Dallas 115
Bremen 102
São Paulo 95
Orem 89
Frankfurt am Main 79
Tampa 76
Boardman 73
Da Nang 72
Rome 71
Elk Grove Village 69
Redwood City 66
Phoenix 63
Des Moines 61
Tokyo 61
Dublin 60
Toronto 60
Atlanta 58
Brussels 55
Nuremberg 55
Warsaw 54
Turku 53
Brooklyn 52
Columbus 52
Chennai 51
Montreal 51
Haiphong 50
Denver 49
Reggio Emilia 49
Miami 45
Guangzhou 40
Amsterdam 38
Boston 38
Dong Ket 38
Mexico City 38
Nairobi 38
Stockholm 38
Parma 37
Vienna 36
Baghdad 35
Sterling 35
Johannesburg 34
Las Vegas 34
Kent 33
Lancaster 33
Ottawa 33
Redondo Beach 33
Manchester 31
Rio de Janeiro 31
San Francisco 30
Tashkent 30
Brno 29
Kilburn 28
Paris 28
Philadelphia 27
Belo Horizonte 26
Totale 34.998
Nome #
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 464
HHV-6A in syncytial giant-cell hepatitis 461
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 441
Kaposi's sarcoma after liver transplantation 421
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 420
B cells and herpesviruses: a model of lymphoproliferation 404
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 403
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 395
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 392
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 388
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 378
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 368
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 361
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 356
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 355
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 355
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 355
Acute appendicitis in adult neutropenic patients with hematologic malignancies 354
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 352
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 350
Early versus delayed palliative/supportive care in advanced cancer: An observational study 350
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 350
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 345
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 343
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 343
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 342
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 340
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 340
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Translational challenges of human herpesvirus 6 chromosomal integration. 338
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 331
Mucorales-specific T cells in patients with hematologic malignancies 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 324
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 323
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 322
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 321
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 320
Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma 320
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 318
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 318
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 318
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 315
Rhodotorula infection in haematological patient: risk factors and outcome 312
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 310
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 309
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 308
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 307
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 305
Parvoviruses in blood donors and transplant patients, Italy 305
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 305
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 304
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 303
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 302
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 302
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 296
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 294
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 293
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 293
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 292
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 292
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 290
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 290
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 289
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 288
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 285
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 283
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals 283
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 282
Breast Location for De Novo Extramedullary Myeloid Sarcoma 282
Diagnosis of aspergillosis: Role of proteomics 282
'Gloves and socks' papular purpuric syndrome following primary infection with parvovirus B19: a link between dermatologists and haematologists 278
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 278
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 278
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 278
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 277
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 274
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 274
Pain and emotional distress in leukemia patients at diagnosis. 273
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 273
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 273
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 270
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 267
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 266
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 266
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 265
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 262
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 261
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 260
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 260
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 259
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 258
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 255
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 254
How I treat HHV8/KSHV-related diseases in posttransplant patients. 252
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 252
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 249
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 248
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis 248
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 247
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response 246
Totale 31.247
Categoria #
all - tutte 196.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021626 0 0 0 0 0 0 0 0 0 0 338 288
2021/20223.733 247 433 370 185 85 173 203 181 349 315 622 570
2022/20234.019 510 454 278 366 545 502 105 429 429 74 167 160
2023/20242.910 102 141 189 267 527 275 313 437 59 90 185 325
2024/20258.829 294 120 157 574 1.524 1.252 628 483 1.254 482 908 1.153
2025/202615.572 1.231 634 1.263 1.851 2.680 1.171 2.188 789 1.634 1.459 672 0
Totale 49.835